This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Ventas Secures Agreements With Kindred & ScionHealth for 23 LTACs
by Zacks Equity Research
To improve patient care facilities, VTR announces reaching an agreement with Kindred and ScionHealth regarding 23 long-term acute care hospitals.
Is it a Wise Decision to Hold Healthpeak Properties Stock Now?
by Zacks Equity Research
DOC is well-poised to gain from high demand for lab assets and rising senior citizens' healthcare spending despite competitive and high interest rate environment.
Gladstone Commercial Grows Industrial Property Base With Acquisition
by Zacks Equity Research
As part of its efforts to expand in strong industrial locations, GOOD acquires an industrial manufacturing, distribution and service facility in Midland, TX.
Is it Wise to Retain SL Green Stock in Your Portfolio Now?
by Zacks Equity Research
SLG is likely to benefit from healthy demand for premier office properties and a solid tenant base despite an elevated supply of office spaces and high interest rates.
Healthpeak Properties' Stock Rises 31% in 6 Months: Here's How
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.
Zacks Industry Outlook Healthpeak Properties, Lamar Advertising and Cousins Properties
by Zacks Equity Research
Healthpeak Properties, Lamar Advertising and Cousins Properties have been highlighted in this Industry Outlook article.
3 Equity REIT Stocks Worth Investing in as the Industry Rebounds
by Moumita C. Chattopadhyay
The Zacks REIT and Equity Trust - Other industry players such as DOC, LAMR and CUZ are likely to benefit from healthy fundamentals and improving demand.
Reasons to Add Healthpeak Properties (DOC) to Your Portfolio Now
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC).
BXP Rallies 19.5% in 3 Months: Will It Continue to Rise?
by Zacks Equity Research
BXP's assets in a few select markets, diversified tenant base, strategic expansions and a solid balance sheet position bode well for future growth.
Iron Mountain (IRM) Uses MongoDB for its New InSight DXP
by Zacks Equity Research
To manage physical and digital information, Iron Mountain (IRM) uses MongoDB Atlas as the data platform for its InSight DXP.
Healthpeak (DOC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Healthpeak (DOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What's in the Cards for Medical Properties (MPW) in Q2 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q2 earnings are likely to have benefited from the favorable healthcare industry trends, high interest rates and exposure to certain troubled operators may have hurt it.
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
SBA Communications' (SBAC) Q2 AFFO Beat, Revenues Fall Y/Y
by Zacks Equity Research
SBA Communications' (SBAC) Q2 results reflect a year-over-year site-leasing revenue growth on healthy leasing activity.
Welltower (WELL) Q2 FFO Beat Estimates, Same Store NOI Rises
by Zacks Equity Research
Welltower's (WELL) Q2 earnings outshine estimates driven by a rise in revenues. SHO portfolio occupancy improves year over year.
Healthpeak's (DOC) Q2 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (DOC) Q2 results outshine estimates on better-than-anticipated revenues. Total merger-combined same-store cash NOI improves year over year. It has revised its 2024 outlook.
Compared to Estimates, Healthpeak (DOC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Healthpeak (DOC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Healthpeak (DOC) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Healthpeak (DOC) delivered FFO and revenue surprises of 2.27% and 5.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Healthpeak (DOC) This Earnings Season?
by Zacks Equity Research
While Healthpeak's (DOC) Q2 earnings are likely to have benefited from the healthy demand for lab real estate assets, high interest expenses raise concern.
Is It Wise to Hold Healthpeak Properties (DOC) Stock Now?
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC). However, competition from peers and higher interest rates are concerns.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Equinix (EQIX) Unveils Dell PowerStore on Equinix Metal Service
by Zacks Equity Research
Equinix (EQIX), with Dell Technologies, announces the availability of Dell PowerStore on Equinix Metal service offering to manage a wide range of high-performance multicloud workloads.
Digital Realty (DLR) to Offer Liquid-to-Chip Cooling Technology
by Zacks Equity Research
Digital Realty (DLR) announces high-density deployment support for liquid-to-chip cooling across its 170 global data centers.
Piedmont (PDM) Announces New Lease at 501 W. Church, Orlando
by Zacks Equity Research
Piedmont's (PDM) securing of a new lease with Travel + Leisure at Downtown, Orlando highlights solid demand for its office buildings.